Literature DB >> 21748754

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.

Lingyi Lu1, Geraldine Cancel-Tassin, Antoine Valeri, Olivier Cussenot, Ethan M Lange, Kathleen A Cooney, James M Farnham, Nicola J Camp, Lisa A Cannon-Albright, Teuvo L J Tammela, Johanna Schleutker, Josef Hoegel, Kathleen Herkommer, Christiane Maier, Walther Vogel, Fredrik Wiklund, Monica Emanuelsson, Henrik Grönberg, Kathleen E Wiley, Sarah D Isaacs, Patrick C Walsh, Brian T Helfand, Donghui Kan, William J Catalona, Janet L Stanford, Liesel M FitzGerald, Bo Johanneson, Kerry Deutsch, Laura McIntosh, Elaine A Ostrander, Stephen N Thibodeau, Shannon K McDonnell, Scott Hebbring, Daniel J Schaid, Alice S Whittemore, Ingrid Oakley-Girvan, Chih-Lin Hsieh, Isaac Powell, Joan E Bailey-Wilson, Cheryl D Cropp, Claire Simpson, John D Carpten, Daniela Seminara, S Lilly Zheng, Jianfen Xu, Graham G Giles, Gianluca Severi, John L Hopper, Dallas R English, William D Foulkes, Lovise Maehle, Pal Moller, Michael D Badzioch, Steve Edwards, Michelle Guy, Ros Eeles, Douglas Easton, William B Isaacs.   

Abstract

BACKGROUND: In spite of intensive efforts, understanding of the genetic aspects of familial prostate cancer (PC) remains largely incomplete. In a previous microsatellite-based linkage scan of 1,233 PC families, we identified suggestive evidence for linkage (i.e., LOD ≥ 1.86) at 5q12, 15q11, 17q21, 22q12, and two loci on 8p, with additional regions implicated in subsets of families defined by age at diagnosis, disease aggressiveness, or number of affected members.
METHODS: In an attempt to replicate these findings and increase linkage resolution, we used the Illumina 6000 SNP linkage panel to perform a genome-wide linkage scan of an independent set of 762 multiplex PC families, collected by 11 International Consortium for Prostate Cancer Genetics (ICPCG) groups.
RESULTS: Of the regions identified previously, modest evidence of replication was observed only on the short arm of chromosome 8, where HLOD scores of 1.63 and 3.60 were observed in the complete set of families and families with young average age at diagnosis, respectively. The most significant linkage signals found in the complete set of families were observed across a broad, 37 cM interval on 4q13-25, with LOD scores ranging from 2.02 to 2.62, increasing to 4.50 in families with older average age at diagnosis. In families with multiple cases presenting with more aggressive disease, LOD scores over 3.0 were observed at 8q24 in the vicinity of previously identified common PC risk variants, as well as MYC, an important gene in PC biology.
CONCLUSIONS: These results will be useful in prioritizing future susceptibility gene discovery efforts in this common cancer.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21748754      PMCID: PMC3568777          DOI: 10.1002/pros.21443

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  41 in total

1.  Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23.

Authors:  J Xu; S L Zheng; G A Hawkins; D A Faith; B Kelly; S D Isaacs; K E Wiley; B Chang ; C M Ewing; P Bujnovszky; J D Carpten; E R Bleecker; P C Walsh; J M Trent; D A Meyers; W B Isaacs
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

2.  8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.

Authors:  Nasim Ahmadiyeh; Mark M Pomerantz; Chiara Grisanzio; Paula Herman; Li Jia; Vanessa Almendro; Housheng Hansen He; Myles Brown; X Shirley Liu; Matt Davis; Jennifer L Caswell; Christine A Beckwith; Adam Hills; Laura Macconaill; Gerhard A Coetzee; Meredith M Regan; Matthew L Freedman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-07       Impact factor: 11.205

3.  Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.

Authors:  Nicola J Camp; James M Farnham; Kristina Allen-Brady; Lisa A Cannon-Albright
Journal:  Prostate       Date:  2007-09-15       Impact factor: 4.104

4.  Multiple loci on 8q24 associated with prostate cancer susceptibility.

Authors:  Ali Amin Al Olama; Zsofia Kote-Jarai; Graham G Giles; Michelle Guy; Jonathan Morrison; Gianluca Severi; Daniel A Leongamornlert; Malgorzata Tymrakiewicz; Sameer Jhavar; Ed Saunders; John L Hopper; Melissa C Southey; Kenneth R Muir; Dallas R English; David P Dearnaley; Audrey T Ardern-Jones; Amanda L Hall; Lynne T O'Brien; Rosemary A Wilkinson; Emma Sawyer; Artitaya Lophatananon; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Colin Cooper; Jenny L Donovan; Freddie C Hamdy; David E Neal; Rosalind A Eeles; Douglas F Easton
Journal:  Nat Genet       Date:  2009-09-20       Impact factor: 38.330

5.  Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.

Authors:  G S Bova; B S Carter; M J Bussemakers; M Emi; Y Fujiwara; N Kyprianou; S C Jacobs; J C Robinson; J I Epstein; P C Walsh
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

Review 6.  Recurrent gene fusions in prostate cancer.

Authors:  Chandan Kumar-Sinha; Scott A Tomlins; Arul M Chinnaiyan
Journal:  Nat Rev Cancer       Date:  2008-06-19       Impact factor: 60.716

7.  Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Robert B Jenkins; Fusheng Lan; Chi Van Dang; Jessica L Hicks; James Morgan; Toby C Cornish; Siobhan Sutcliffe; William B Isaacs; Jun Luo; Angelo M De Marzo
Journal:  Mod Pathol       Date:  2008-06-20       Impact factor: 7.842

8.  Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Thorarinn Blondal; Arnaldur Gylfason; Bjarni A Agnarsson; Kristrun R Benediktsdottir; Droplaug N Magnusdottir; Gudbjorg Orlygsdottir; Margret Jakobsdottir; Simon N Stacey; Asgeir Sigurdsson; Tiina Wahlfors; Teuvo Tammela; Joan P Breyer; Kate M McReynolds; Kevin M Bradley; Berta Saez; Javier Godino; Sebastian Navarrete; Fernando Fuertes; Laura Murillo; Eduardo Polo; Katja K Aben; Inge M van Oort; Brian K Suarez; Brian T Helfand; Donghui Kan; Carlo Zanon; Michael L Frigge; Kristleifur Kristjansson; Jeffrey R Gulcher; Gudmundur V Einarsson; Eirikur Jonsson; William J Catalona; Jose I Mayordomo; Lambertus A Kiemeney; Jeffrey R Smith; Johanna Schleutker; Rosa B Barkardottir; Augustine Kong; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2009-09-20       Impact factor: 38.330

9.  Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.

Authors:  Norihiko Tsuchiya; Jeffrey M Slezak; Michael M Lieber; Erik J Bergstralh; Robert B Jenkins
Journal:  Genes Chromosomes Cancer       Date:  2002-08       Impact factor: 5.006

10.  Functional enhancers at the gene-poor 8q24 cancer-linked locus.

Authors:  Li Jia; Gilad Landan; Mark Pomerantz; Rami Jaschek; Paula Herman; David Reich; Chunli Yan; Omar Khalid; Phil Kantoff; William Oh; J Robert Manak; Benjamin P Berman; Brian E Henderson; Baruch Frenkel; Christopher A Haiman; Matthew Freedman; Amos Tanay; Gerhard A Coetzee
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

View more
  9 in total

1.  Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis.

Authors:  Claire L Simpson; Cheryl D Cropp; Tiina Wahlfors; Asha George; Marypat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Teuvo Tammela; Johanna Schleutker; Joan E Bailey-Wilson
Journal:  Eur J Hum Genet       Date:  2012-09-05       Impact factor: 4.246

2.  The 2013 Genetics Society of America Medal: Elaine A. Ostrander.

Authors:  John Schimenti; Marnie Halpern
Journal:  Genetics       Date:  2013-05       Impact factor: 4.562

3.  Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer.

Authors:  Paula J Hurley; Debasish Sundi; Brian Shinder; Brian W Simons; Robert M Hughes; Rebecca M Miller; Benjamin Benzon; Sheila F Faraj; George J Netto; Ismael A Vergara; Nicholas Erho; Elai Davicioni; R Jeffrey Karnes; Guifang Yan; Charles Ewing; Sarah D Isaacs; David M Berman; Jennifer R Rider; Kristina M Jordahl; Lorelei A Mucci; Jessie Huang; Steven S An; Ben H Park; William B Isaacs; Luigi Marchionni; Ashley E Ross; Edward M Schaeffer
Journal:  Clin Cancer Res       Date:  2015-10-07       Impact factor: 12.531

4.  Prostate cancer risk-associated genetic markers and their potential clinical utility.

Authors:  Jianfeng Xu; Jielin Sun; S Lilly Zheng
Journal:  Asian J Androl       Date:  2013-04-08       Impact factor: 3.285

Review 5.  The genetic epidemiology of prostate cancer and its clinical implications.

Authors:  Rosalind Eeles; Chee Goh; Elena Castro; Elizabeth Bancroft; Michelle Guy; Ali Amin Al Olama; Douglas Easton; Zsofia Kote-Jarai
Journal:  Nat Rev Urol       Date:  2013-12-03       Impact factor: 14.432

6.  Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22.

Authors:  Mine S Cicek; Julie M Cunningham; Brooke L Fridley; Daniel J Serie; William R Bamlet; Brenda Diergaarde; Robert W Haile; Loic Le Marchand; Theodore G Krontiris; H Banfield Younghusband; Steven Gallinger; Polly A Newcomb; John L Hopper; Mark A Jenkins; Graham Casey; Fredrick Schumacher; Zhu Chen; Melissa S DeRycke; Allyson S Templeton; Ingrid Winship; Roger C Green; Jane S Green; Finlay A Macrae; Susan Parry; Graeme P Young; Joanne P Young; Daniel Buchanan; Duncan C Thomas; D Timothy Bishop; Noralane M Lindor; Stephen N Thibodeau; John D Potter; Ellen L Goode
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

7.  Association of a Novel KIF26B Gene Polymorphism with Susceptibility to Schizophrenia and Breast Cancer: A Case-Control Study.

Authors:  Saman Sargazi; Milad Heidari Nia; Shekoufeh Mirinejad; Mahdiyeh Moudi; Mahdiyeh Jafari Shahroudi; Ramin Saravani; Sadegh Valian-Borojeni
Journal:  Iran J Public Health       Date:  2021-02       Impact factor: 1.429

Review 8.  Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.

Authors:  Brennan Decker; Elaine A Ostrander
Journal:  Pharmgenomics Pers Med       Date:  2014-08-05

9.  Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.

Authors:  Jean M Winter; Natasha L Curry; Derek M Gildea; Kendra A Williams; Minnkyong Lee; Ying Hu; Nigel P S Crawford
Journal:  BMC Genomics       Date:  2018-06-11       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.